Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06221462
What this trial is testing

Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ningbo No.2 Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT07642024
What this trial is testing

BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer(PANKU-Lung09)

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06644313
What this trial is testing

Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Potentially Resectable MET-altered Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 31
Testing effectiveness (Phase 2)Looking for participantsNCT05536505
What this trial is testing

Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC

Who this might be right for
MRD
Guangdong Association of Clinical Trials 180
Testing effectiveness (Phase 2)Looking for participantsNCT04933903
What this trial is testing

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Who this might be right for
Non Small Cell Lung Cancer
Brown University 25
Not applicableStudy completedNCT03736993
What this trial is testing

Metabolomics Predict Therapy Response

Who this might be right for
NSCLC, Stage IIIA
Hasselt University 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07281209
What this trial is testing

SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable HER2-Altered Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Shanghai Chest Hospital 40
Large-scale testing (Phase 3)Study completedNCT00321334
What this trial is testing

Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC

Who this might be right for
Non-small Cell Lung Cancer
Chinese Society of Lung Cancer 410
Testing effectiveness (Phase 2)Looking for participantsNCT06877299
What this trial is testing

Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
Sichuan University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06755684
What this trial is testing

Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer

Who this might be right for
EGFRNon-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung Cancer+5 more
Peng Zhang 60
Not applicableLooking for participantsNCT06057766
What this trial is testing

Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNon-small Cell Carcinoma
University Hospital, Ghent 90
Testing effectiveness (Phase 2)Study completedNCT04205552
What this trial is testing

Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients

Who this might be right for
NSCLC Stage IINSCLC, Stage IIIANSCLC, Stage I
University Hospital, Essen 90
Not applicableNot Yet RecruitingNCT06552000
What this trial is testing

Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer

Who this might be right for
NSCLCNon Small Cell Lung Cancer
University of Texas Southwestern Medical Center 18
Early research (Phase 1)Study completedNCT03131037
What this trial is testing

Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Candel Therapeutics, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT05295212
What this trial is testing

Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03433469
What this trial is testing

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

Who this might be right for
Stage I Non-Small Cell Lung CancerStage IA Non-Small Cell Lung CancerStage IB Non-Small Cell Lung Cancer+4 more
University of California, San Francisco 27
Large-scale testing (Phase 3)Looking for participantsNCT07251582
What this trial is testing

Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer

Who this might be right for
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
Hunan Province Tumor Hospital 186
Testing effectiveness (Phase 2)Looking for participantsNCT06775275
What this trial is testing

Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC

Who this might be right for
Resectable Lung Non-Small Cell Carcinoma
The First Affiliated Hospital of Guangzhou Medical University 60
Not applicableStudy completedNCT06735781
What this trial is testing

Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in France

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 101
Testing effectiveness (Phase 2)WithdrawnNCT05400577
What this trial is testing

Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Fox Chase Cancer Center
Next Page